Best GLP-1 on Aetna Formulary in 2026: The One to Ask For First

Here’s the thing nobody says out loud, and it’s the whole game: two people who both “have Aetna” can get opposite answers at the pharmacy counter. Not because one did something wrong — because “Aetna” isn’t one plan. Which GLP-1 lands in your covered column comes down to your diagnosis, your specific plan, and one hidden switch we’ll show you how to check in about two minutes. Get that right and this stops being confusing. Get it wrong and you can spend weeks fighting a denial you didn’t need to file.

(Quick definition: a GLP-1 is a type of medicine — like semaglutide or tirzepatide — that lowers blood sugar and quiets appetite. Brand names include Ozempic, Wegovy, Mounjaro, and Zepbound.)

Your pick in 10 seconds

What is the best GLP-1 on Aetna formulary right now?

On Aetna’s two most common commercial drug lists (the Standard and Advanced Control formularies), Wegovy is the preferred weight-loss GLP-1 as of mid-2026 — its pen, pill, and higher-dose “HD” form are all preferred. Foundayo, the new oral pill, is listed as a non-preferred option, and Zepbound is off the standard list until October 1, 2026. For diabetes, Ozempic, Mounjaro, Rybelsus, and Trulicity are the covered options. “Preferred” means lower hurdles — not a guarantee you’re covered.

Let’s be plain about what “best on the formulary” means. It doesn’t mean the drug that works best for your body — that’s between you and your doctor. It means the drug your plan puts in the front row: on the list, on a preferred tier, with the smoothest path to a yes. Right now, for weight loss, that’s Wegovy.

Why Wegovy and not Zepbound? Because of a date most people never heard about.

The CVS Caremark timeline (this is the source of all the confusion)

CVS Caremark is the PBM — the pharmacy benefit manager, the company that decides which drugs sit on the list and negotiates their prices for Aetna. Aetna is a CVS Health company, so for most Aetna commercial members, Caremark’s decisions shape your formulary (though your employer can still customize the list). Three dates are on the record:

• •July 1, 2025 — CVS Caremark dropped Zepbound from its standard formulary and made Wegovy the preferred weight-loss GLP-1. A lot of people on Zepbound got a letter and had to scramble. (Managed Healthcare Executive, Drug Topics.)
• •June 1, 2026 — CVS Caremark removed the “new-to-market” block on Foundayo (the new oral pill), so plans can cover it if they opt in. (CVS Health, May 28, 2026.)
• •October 1, 2026 — CVS Caremark plans to add Zepbound back as an additional preferred option — for plan sponsors that cover weight-loss drugs and adopt the change. (CVS Health, May 28, 2026.)

So the honest answer shifts by the calendar. Through September 30, 2026, on a standard Aetna/CVS Caremark plan, Wegovy is your covered weight-loss GLP-1 and Zepbound usually isn’t yet. For many plans that opens up on October 1 — but “scheduled” isn’t “guaranteed for every plan,” so recheck your own before counting on it.

FDA-approved ≠ covered: the 5 things that decide your coverage

A GLP-1 being FDA-approved, or even sitting right there on Aetna’s list, does not mean your plan will pay for it. Five separate things all have to line up. Miss any one — most often the employer benefit or the prior-authorization criteria — and you can be denied even though the drug is on the formulary.

This is the single biggest source of “wait, I thought I was covered?” Here’s the whole picture on one screen:

Keep this in your head as you read the rest. Every “yes” or “no” you get from Aetna traces back to one of these five rows — and knowing which row is blocking you tells you exactly what to do next.

Which GLP-1 is best for your situation?

The best GLP-1 on Aetna changes with your diagnosis, because the same medicine can be covered as a diabetes drug, a weight-loss drug, a heart-risk drug, a sleep-apnea drug, or a liver-disease drug — and each has its own FDA-approved use and its own Aetna criteria. Matching your situation to the right one is what a denied “wrong-lane” request was missing. It still isn’t a guarantee — your plan makes the final call.

Find your row, and you’ve found your first move:

Wegovy vs. Zepbound on Aetna: which one wins?

Through September 30, 2026, Wegovy wins on Aetna’s standard formulary — it’s preferred, and Zepbound is off most standard lists. CVS Caremark plans to bring Zepbound back as a preferred option on October 1, 2026 for plan sponsors that adopt the change, which makes it a real option again on those plans. If you have moderate-to-severe sleep apnea, Zepbound has its own covered path regardless of the weight-loss timeline.

What the October 1 change does — and doesn’t — do. It means Zepbound is scheduled to be a preferred option again, and on many plans it’ll get easier to cover. It does not mean every Aetna plan suddenly covers Zepbound, that every dose is cheap, or that an old denial clears itself. It still sits underneath your employer’s choice to cover weight-loss drugs at all.

Does Aetna prefer the Wegovy pill or Foundayo?

On Aetna’s two common commercial drug lists, the Wegovy oral tablet is on a preferred tier and Foundayo (orforglipron) is listed as non-preferred. They’re different FDA-approved medicines — different active drugs, dosing, and coverage positions — so don’t treat them as interchangeable. Verify the exact product on your plan, because a template tier doesn’t prove your coverage or your cost.

Oral GLP-1s are the newest twist, and coverage is genuinely two-tiered right now:

• •Wegovy oral tablet — Wegovy now comes as a pill, not just a pen, and it shows up on a preferred tier on the common lists (with prior approval). Confirm it specifically: some plans list the pen but not the pill, or the reverse.
• •Foundayo (orforglipron) — FDA-approved on April 1, 2026, it’s the first GLP-1 weight-loss pill you can take any time of day without food or water restrictions. CVS Caremark cleared the way for coverage on June 1, 2026, but it’s listed as a non-preferred option, so expect a bit more friction. Non-preferred doesn’t mean “no” — it means check your plan, your prior-auth path, and your cost.

Does your Aetna plan even cover weight-loss drugs? (This decides everything)

The single biggest factor in whether Aetna covers a GLP-1 for weight loss isn’t the drug, your weight, or your doctor — it’s whether your employer paid to include weight-loss drugs in your plan. Aetna lets plan sponsors turn that benefit on or off, and plenty leave it off to control cost. When a plan carves it out, prior authorization can’t save you: you can meet every clinical rule and still be denied, because the benefit simply isn’t there.

So before you do anything else, answer one question: is weight-loss coverage switched on in my plan? Five minutes with HR or the number on your card settles it — and it tells you whether you’re fighting for a covered drug or you need a different door.

What does Aetna require before it covers a weight-loss GLP-1?

For a weight-loss GLP-1, Aetna’s prior authorization generally asks for age 18 or older, a qualifying BMI, and proof of about 6 months in a weight-management program — plus, to keep it going, roughly 5% weight loss after you reach a steady dose. The exact BMI cutoff depends on which Aetna policy your plan uses, and if your plan excludes the benefit, none of this applies.

Here’s the honest picture on the BMI number, because it trips everyone up:

Aetna doesn’t use one BMI cutoff. It depends on which of its weight-management drug policies applies to your plan — and Aetna has more than one. Some Aetna policies require a BMI of 35 or higher; others use the standard obesity threshold of 30 or higher, or 27 or higher with a weight-related condition (like high blood pressure, high cholesterol, sleep apnea, or type 2 diabetes). Both appear in Aetna’s own published policies. Add age 18+ and, on the standard path, documentation of about 6 months in a real weight-management program (diet, activity, behavior changes). The only number you can count on is the one printed in your plan’s drug policy — so pull it before you assume you do or don’t qualify. If your BMI is in the low-to-mid 30s, don’t rule yourself out; confirm which policy your plan uses.

The shortcut: let someone handle the paperwork

Prior authorization is the single most exhausting part of getting a GLP-1 — the forms, the back-and-forth, the denials. This is where a telehealth provider with a real insurance team earns its keep. Here’s an honest side-by-side of the two we’d point Aetna members to:

Provider terms verified July 2026. Neither one can guarantee Aetna covers your drug — that’s your plan’s call.

Ro is our pick for Aetna prior authorization. Its free checker contacts your insurer to build a coverage report; it doesn’t write a prescription or submit a prior auth. If you then join Ro Body and a Ro-affiliated provider prescribes an eligible medication that needs approval, Ro’s insurance concierge verifies your benefits, submits and coordinates the prior-authorization paperwork, communicates with your insurer, and helps with an appeal if you’re denied. The insurer still makes the coverage decision — no provider can promise a yes.

One honest catch: Ro isn’t free, and that membership sits on top of your medication cost. If you already have a prescriber who’ll verify your benefits, submit the prior auth, and manage follow-up, Ro’s membership may duplicate care you already have. But if your real block is insurance — the paperwork, the denials, the runaround — that concierge does the exact work you’d otherwise grind through alone. (Ro’s insurance help currently covers commercial and FEHB plans; on Medicare, a Medicare supplement, or TRICARE you may be limited to cash-pay options, and Medicaid isn’t eligible — read the Medicare section below.)

Safety note: GLP-1 medications carry serious warnings, including a boxed warning about thyroid tumors, and possible side effects. Read the FDA Medication Guide for your specific drug and talk with a licensed clinician about whether it’s right for you.

Prefer to choose your own clinician? Sesame Care (sponsored affiliate link, opens in a new tab) (sponsored affiliate link, opens in a new tab) starts at $59/month on an annual plan, with medication billed separately.

What if Aetna denies your GLP-1?

A denial isn’t the end — but the fix depends entirely on why you were denied. The five common reasons are: prior-auth criteria not met, step therapy, non-formulary, quantity limit, and excluded benefit. Each has a different solution. Read the denial letter first, find your reason, then match it below.

How fast must Aetna decide? Go by the deadline printed on your notice. As one benchmark, Aetna says it decides within 24 hours of an urgent, expedited medical-exception request — but that 24-hour clock applies only to those urgent requests. Regular prior authorizations, exceptions, and appeals have their own deadlines.

What if your plan excludes weight-loss drugs completely?

If your Aetna plan carves out weight-loss medications, prior authorization won’t help — you need a different strategy. Your four options: qualify under a different covered diagnosis, ask HR whether the benefit can be added, use an FDA-approved cash-pay program, or compare compounded cash-pay as a clearly-separated last resort.

Does this Aetna answer apply to Medicare or Medicaid?

No — this page covers Aetna commercial plans. Aetna Medicare and Aetna Better Health (Medicaid) use different formularies and different rules. Regular Medicare Part D still can’t pay for drugs used only for weight loss, but the new Medicare GLP-1 Bridge changed the picture on July 1, 2026.

How to check your exact Aetna GLP-1 coverage in 2 minutes

The only truly reliable answer is the one tied to your specific plan. Log in to your Aetna member portal (or open your plan’s drug list), search each drug by exact brand name, and write down whether it’s covered, its tier, and whether it needs prior approval, step therapy, or has quantity limits. Then call the number on your card to confirm your cost.

1. 1
   Find your pharmacy plan name. It’s on your Summary of Benefits and Coverage, or you’ll see it after logging in. Aetna needs this to show your coverage, not a generic list.
2. 2
   Search each drug by exact name: Wegovy, Wegovy oral tablet, Wegovy HD, Zepbound, Zepbound KwikPen, Ozempic, Mounjaro, Rybelsus, Trulicity, Saxenda, Foundayo — plus the ingredients semaglutide, tirzepatide, orforglipron.
3. 3
   Write down the status for each: Covered? What tier? Prior approval? Step therapy? Quantity limit? Non-formulary? Diagnosis required? Estimated cost?
4. 4
   Call and ask the exact questions.

   “For my plan, is [drug] covered under the pharmacy benefit for [my reason]? Are weight-loss medications excluded? What exact prior-authorization criteria does my prescriber need to submit? And is my plan adopting the October 1, 2026 Zepbound change?”

How did The RX Index verify this guide?

We built this from primary and authoritative sources: Aetna’s public 2026 drug guides and Clinical Policy Bulletins, Aetna’s Medicare and employer coverage pages, CVS Caremark’s 2026 formulary announcements, CMS and Medicare.gov for the GLP-1 Bridge, and the FDA’s approval records. We used patient forums only to understand where people get confused — never as evidence of coverage. Your exact coverage can still differ, because Aetna requires your pharmacy plan name or member login for personalized results.

What we verified (July 2026): the status of each named drug on Aetna’s two common commercial drug lists; that Aetna lets employers include or exclude weight-loss coverage; the CVS Caremark timeline (Zepbound dropped July 1, 2025; Foundayo block removed June 1, 2026; Zepbound scheduled to return October 1, 2026); the Medicare GLP-1 Bridge covered drugs, $50 copay, and dates; Foundayo’s FDA approval (April 1, 2026); and current provider pricing and program terms.

Who wrote this and why. This guide was produced by The RX Index Editorial Team. We wrote it because “does Aetna cover a GLP-1?” hides four different answers — the general formulary, your employer’s benefit, your exact plan, and your diagnosis — and our job is to show those layers together and tell you which one to check next. We don’t decide your coverage; Aetna and your plan documents do, and your prescriber decides what’s medically appropriate. Provider links are added only after the coverage answer, and they never change what we report.

Frequently asked questions

Related guides

• ›Best GLP-1 Providers That Accept Insurance
• ›How to Bypass Step Therapy with Aetna
• ›Aetna Wegovy Prior Authorization Guide
• ›Medicare GLP-1 Bridge Tracker (2026)
• ›What GLP-1 Does Cigna Cover? 2026 Drug List